Sort
23,748 grants matching “melanoma”
Role of CDK4 in Cell Cycle Progression and Cancer
$376,250Temple University · R01 · FY2005 · AG
Role of CDK4 in Cell Cycle Progression and Cancer
$376,250Temple University · R01 · FY2004 · AG
Role of CDK4 in Cell Cycle Progression and Cancer
$376,250Temple University · R01 · FY2003 · AG
Mechanism-based strategies to target oncogenic BRAF signaling
$376,248Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
The CXCR3 Chemokine System in Cancer Immunotherapy
$376,216Andrew D Luster · Massachusetts General Hospital · R01 · FY2020 · CA
The CXCR3 Chemokine System in Cancer Immunotherapy
$376,216Andrew D Luster · Massachusetts General Hospital · R01 · FY2021 · CA
Melanoma detection by optical spectroscopy
$376,210Texas Engineering Experiment Station · R01 · FY2005 · CA
In vivo murine models of metastasis for therapeutic testing
$376,196Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2013 · CA
Non-deletional CD8 T cell self-tolerance
$376,174Stephen C Jameson · University Of Minnesota · P01 · FY2020 · AI
NK cell exhaustion in metastatic melanoma
$376,099Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
$376,098Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
$376,098Sohail F. Tavazoie · Rockefeller University · R01 · FY2019 · CA
Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancer
$376,043Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P50 · FY2022 · CA
CLINICAL DIAGNOSTICS USING NONLINEAR OPTICAL IMAGING
$376,035University Of Calif-Lawrnc Lvrmr Nat Lab · R01 · FY2000 · AR
MELANOMA CONTROL FOR SIBLING OF MELANOMA PATIENTS
$376,000Boston University Medical Campus · R01 · FY2000 · CA
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients
$375,966Craig A Elmets · University Of Alabama At Birmingham · P01 · FY2020 · CA
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation
$375,903Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
An S-Plus Functional Data Analysis Module
$375,806Insightful Corporation · R44 · FY2002 · CA
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
$375,750James J Mule · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
CLINICAL DIAGNOSTICS USING NONLINEAR OPTICAL IMAGING
$375,621University Of Calif-Lawrnc Lvrmr Nat Lab · R01 · FY2002 · EB
The Inflammasome as a novel mediator and therapeutic target of GI syndrome
$375,493Richard A Flavell · Yale University · R01 · FY2022 · CA
Linking Genetic, Epigenetic and Signaling Mechanisms of Oncogene Addiction
$375,444Mohammad Fallahi-Sichani · University Of Virginia · R01 · FY2021 · CA
Biogenesis of Melanosomes
$375,440Seth J. Orlow · New York University School Of Medicine · R01 · FY2006 · AR
T4 Endonuclease V Structure-Function Analysis
$375,435R Stephen Lloyd · Oregon Health & Science University · R01 · FY2006 · ES
Reprogramming of the stromal microenvironment in melanoma progression and therapeutic escape
$375,431Yuhang Zhang · University Of Cincinnati · R01 · FY2021 · CA